🎉 20 Years of #WorldKidneyDay! 🎉

Since its launch, World Kidney Day has raised global awareness of kidney health. The 2025 campaign #AreYourKidneysOK highlights the importance of #EarlyDetection in preventing and managing kidney disease.
🔗 Learn more: www.worldkidneyday.o...
#KidneyHealthMatters

🚨 Looking through the same lens, yet seeing different pictures!

New publication in @ndt-era.bsky.social on eGFR measurement with different equations and its corresponding risk on mortality, kidney failure, and AKI. >250k patients from @umcutrecht.bsky.social.

academic.oup.com/ndt/article/...

High-dose HDF results in increased QALYs at higher costs compared to HD, mainly due to increased dialysis costs. Yet, probability of HDF being cost-effective, across different thresholds, is very high.

@kidneyint.bsky.social, @theisn.org @umcutrecht.bsky.social @nephjc.bsky.social

TOP 12A: HDF Pooling Project by Drs.
@robinvernooij.bsky.social, Bots et al.

thelancet.com/journals/lan...

In a meta-analysis, online HDF reduces all-cause mortality in dialysis patients compared to HD; the risk reduction appears to be dose-dependent.

Advantage of this IPD meta-analysis is that we overcome certain limitations of individual studies, e.g. lack of power, no randomisation to high-dose HDF, and no power for subgroup analyses.

Yet, methodological and clinical heterogeneity is always an issue in meta-analysing studies.

Thanks @hswapnil.bsky.social and @nephroseeker.bsky.social for discussing our paper.

Obviously also curious on the results of H4RT, will add a lot of new information to the puzzle.